USD 9.7
(-3.1%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -2.47 Million USD | -115.2% |
2022 | 16.31 Million USD | 457.72% |
2021 | 2.92 Million USD | 241.12% |
2020 | -2.07 Million USD | -135.63% |
2019 | 5.81 Million USD | 176.37% |
2018 | -7.61 Million USD | -144.43% |
2017 | -3.11 Million USD | -16.35% |
2016 | -2.67 Million USD | 83.48% |
2015 | -16.21 Million USD | 22.05% |
2014 | -20.79 Million USD | -491.36% |
2013 | -3.51 Million USD | 1.37% |
2012 | -3.56 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -4.57 Million USD | 12.8% |
2024 Q1 | -5.25 Million USD | -111.83% |
2023 Q4 | -2.47 Million USD | -128.79% |
2023 Q1 | 13.14 Million USD | -19.43% |
2023 Q2 | 14.38 Million USD | 9.45% |
2023 Q3 | 8.61 Million USD | -40.12% |
2023 FY | -2.47 Million USD | -115.2% |
2022 Q3 | 14.21 Million USD | -8.98% |
2022 Q4 | 16.31 Million USD | 14.72% |
2022 FY | 16.31 Million USD | 457.72% |
2022 Q1 | 5.92 Million USD | 102.49% |
2022 Q2 | 15.62 Million USD | 163.77% |
2021 Q4 | 2.92 Million USD | 99.23% |
2021 Q3 | 1.46 Million USD | -6.01% |
2021 FY | 2.92 Million USD | 241.12% |
2021 Q2 | 1.56 Million USD | 676.36% |
2021 Q1 | -270.98 Thousand USD | 86.92% |
2020 Q4 | -2.07 Million USD | -1146.78% |
2020 FY | -2.07 Million USD | -135.63% |
2020 Q3 | 197.98 Thousand USD | -95.67% |
2020 Q2 | 4.57 Million USD | -21.7% |
2020 Q1 | 5.84 Million USD | 0.46% |
2019 Q4 | 5.81 Million USD | -19.56% |
2019 FY | 5.81 Million USD | 176.37% |
2019 Q1 | 3.85 Million USD | 150.57% |
2019 Q2 | 2.46 Million USD | -36.09% |
2019 Q3 | 7.23 Million USD | 193.73% |
2018 Q4 | -7.61 Million USD | -68.85% |
2018 FY | -7.61 Million USD | -144.43% |
2018 Q1 | -2.93 Million USD | 5.86% |
2018 Q2 | -3.48 Million USD | -18.72% |
2018 Q3 | -4.51 Million USD | -29.51% |
2017 Q2 | -1.94 Million USD | -29.04% |
2017 Q1 | -1.5 Million USD | 43.67% |
2017 Q4 | -3.11 Million USD | -103.85% |
2017 FY | -3.11 Million USD | -16.35% |
2017 Q3 | -1.52 Million USD | 21.48% |
2016 Q3 | -3.05 Million USD | 45.14% |
2016 Q1 | -9.9 Million USD | 38.89% |
2016 Q2 | -5.56 Million USD | 43.79% |
2016 FY | -2.67 Million USD | 83.48% |
2016 Q4 | -2.67 Million USD | 12.33% |
2015 FY | -16.21 Million USD | 22.05% |
2015 Q2 | -11.96 Million USD | 28.92% |
2015 Q1 | -16.82 Million USD | 19.08% |
2015 Q4 | -16.21 Million USD | -82.4% |
2015 Q3 | -8.88 Million USD | 25.69% |
2014 Q3 | -2.37 Million USD | 27.2% |
2014 FY | -20.79 Million USD | -491.36% |
2014 Q4 | -20.79 Million USD | -776.05% |
2014 Q2 | -3.26 Million USD | 0.0% |
2013 Q4 | -3.51 Million USD | 0.0% |
2013 FY | -3.51 Million USD | 1.37% |
2012 FY | -3.56 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.41 Billion USD | 100.176% |
Addus HomeCare Corporation | 110.39 Million USD | 102.246% |
AirSculpt Technologies, Inc. | 89.4 Million USD | 102.773% |
Amedisys, Inc. | 341.35 Million USD | 100.726% |
American Oncology Network, Inc. | 99.78 Million USD | 102.485% |
Astrana Health, Inc. | 27.2 Million USD | 109.113% |
Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 100.17% |
IMAC Holdings, Inc. | -221.51 Thousand USD | -1019.339% |
biote Corp. | 25.86 Million USD | 109.585% |
Cryo-Cell International, Inc. | 10.48 Million USD | 123.636% |
Cross Country Healthcare, Inc. | -11.82 Million USD | 79.036% |
COMPASS Pathways plc | -187.58 Million USD | 98.678% |
DocGo Inc. | -12.78 Million USD | 80.613% |
The Ensign Group, Inc. | 1.36 Billion USD | 100.182% |
Healthcare Services Group, Inc. | -10.69 Million USD | 76.817% |
InnovAge Holding Corp. | 56.08 Million USD | 104.421% |
Assure Holdings Corp. | 14.68 Million USD | 116.888% |
LifeStance Health Group, Inc. | 432.21 Million USD | 100.574% |
Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 59.021% |
ModivCare Inc. | 1.13 Billion USD | 100.218% |
NewGenIvf Group Limited | 278.44 Thousand USD | 990.454% |
Novo Integrated Sciences, Inc. | 4.05 Million USD | 161.141% |
Option Care Health, Inc. | 822.56 Million USD | 100.301% |
P3 Health Partners Inc. | 83.7 Million USD | 102.962% |
P3 Health Partners Inc. | 83.7 Million USD | 102.962% |
The Pennant Group, Inc. | 323.57 Million USD | 100.766% |
Surgery Partners, Inc. | 2.86 Billion USD | 100.087% |
Syra Health Corp. Class A Common Stock | -3.03 Million USD | 18.223% |
Talkspace, Inc. | -123.9 Million USD | 97.999% |
Talkspace, Inc. | -123.9 Million USD | 97.999% |
The Oncology Institute, Inc. | 86.32 Million USD | 102.872% |
The Oncology Institute, Inc. | 86.32 Million USD | 102.872% |